WP3 - Creation of a biological biobank and clinical Data Warehouse

The overall objective of WP3 is to collect, process and store cells and genomic material after having obtained written informed consent from adult leukemia patients, retrospectively and prospectively enrolled in National and European clinical trials with conventional chemotherapy, monoclonal antibodies or tyrosine kinase inhibitors (TKIs).

In particular WP3 is devoted to the creation of a biological and clinical biobank within each clinical unit, as well as a unique Data Warehouse including all biological and clinical features collected within the project.